Cart
sales@molnova.com
Raspberry ketone glucoside
CAS No. 38963-94-9
Raspberry ketone glucoside( —— )
Catalog No. M21259 CAS No. 38963-94-9
Raspberry ketone glucoside is a natural product in raspberry fruit has lasting effects for the inhibition of melanogenesis and various melanogenic factors after the degradation in the skin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 35 | Get Quote |
|
| 200MG | 50 | Get Quote |
|
| 500MG | 82 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRaspberry ketone glucoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionRaspberry ketone glucoside is a natural product in raspberry fruit has lasting effects for the inhibition of melanogenesis and various melanogenic factors after the degradation in the skin.
-
DescriptionRaspberry ketone glucoside is a natural product in raspberry fruit has lasting effects for the inhibition of melanogenesis and various melanogenic factors after the degradation in the skin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38963-94-9
-
Formula Weight326.34
-
Molecular FormulaC16H22O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (153.21 mM)
-
SMILESCC(CCc(cc1)ccc1O[C@@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
DCZ0415
DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.
-
Artemetin
Artemetin protects endothelial function by acting as antioxidant and antiapoptotic agent and through the activation of ERK1/2 and Akt.
-
PLH1215
PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
